Comparison

Human EGFRvIII-coupled Magnetic Beads European Partner

Item no. MBS-K020-10mg
Manufacturer ACROBiosystems
Amount 10 mg
Quantity options 10 mg 2 mg
Category
Type Magnetic Particles
Format Solid
Applications FC
Specific against Human (Homo sapiens)
ECLASS 10.1 32170390
ECLASS 11.0 32170390
UNSPSC 41105507
Shipping Condition Room temperature
Available
Manufacturer - Applications
This product is intended for immunocapture, biopanning. This is a non-sterile product.
Manufacturer - Category
Beads / Protein-coupled magnetic beads
Manufacturer - Conjugate / Tag
Antibody Purification:
1. Resuspend the lyophilized beads by adding the buffer of choice.
2. Add analyte to the suspension, mix and incubate to enable specific binding of the beads and the target protein.
3. Magnetize beads, remove supernatant, and wash unbound protein fractions to capture target protein-bound beads.
4. Wash, magnetize the beads and collect purified target protein for use in downstream applications.
Shipping Temperature
RT
Storage Conditions
-20°C, avoid light
Kit Components
Antibody Purification:
1. Resuspend the lyophilized beads by adding the buffer of choice.
2. Add analyte to the suspension, mix and incubate to enable specific binding of the beads and the target protein.
3. Magnetize beads, remove supernatant, and wash unbound protein fractions to capture target protein-bound beads.
4. Wash, magnetize the beads and collect purified target protein for use in downstream applications.
Manufacturer - Format
Powder
Description
Human EGFRvIII-coupled Magnetic Beads is expressed from Human -.
Background
The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.
The type III EGF deletion mutant receptor (EGFRvIII) is the most common mutation and was first identified in primary human glioblastoma tumors. This tumor-specific antigen is ligand-independent, contains a constitutively active tyrosine kinase domain, and has been shown to be present in a number of human malignancies. EGFRvIII has been selected as a target for CAR-modified T-cell studies in recent years.
Molecule
EGFRvIII
Stability
Upon receipt, please store the beads at -20°C. The shelf life is 6 months at -20 °C._x000D_Please avoid more than 3 freeze-thaw cycles once reconstitution, immediate use after reconstitution is highly recommended.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Delivery expected until 7/24/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?